These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 8761717)

  • 21. Risk-benefit assessment of therapies for Mycobacterium avium complex infections.
    Griffith DE
    Drug Saf; 1999 Aug; 21(2):137-52. PubMed ID: 10456381
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical aspects of mycobacterial infections in HIV infection.
    Coker RJ; Hellyer TJ; Brown IN; Weber JN
    Res Microbiol; 1992 May; 143(4):377-81. PubMed ID: 1455064
    [No Abstract]   [Full Text] [Related]  

  • 23. Recent development in the treatment and prevention of disseminated Mycobacterium avium complex (MAC).
    Schouten JT; Whittemore S
    STEP Perspect; 1996; 8(3):5-6. PubMed ID: 11364267
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Clinical aspects and therapy of ubiquitous mycobacterioses].
    Fätkenheuer G; Diehl V; Schrappe M
    Internist (Berl); 1995 Oct; 36(10):987-94. PubMed ID: 7499075
    [No Abstract]   [Full Text] [Related]  

  • 25. Determinants of rifabutin-associated uveitis in patients treated with rifabutin, clarithromycin, and ethambutol for Mycobacterium avium complex bacteremia: a multivariate analysis. Canadian HIV Trials Network Protocol 010 Study Group.
    Shafran SD; Singer J; Zarowny DP; Deschênes J; Phillips P; Turgeon F; Aoki FY; Toma E; Miller M; Duperval R; Lemieux C; Schlech WF
    J Infect Dis; 1998 Jan; 177(1):252-5. PubMed ID: 9419201
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A prospective randomized trial of four three-drug regimens in the treatment of disseminated Mycobacterium avium complex disease in AIDS patients: excess mortality associated with high-dose clarithromycin. Terry Beirn Community Programs for Clinical Research on AIDS.
    Cohn DL; Fisher EJ; Peng GT; Hodges JS; Chesnut J; Child CC; Franchino B; Gibert CL; El-Sadr W; Hafner R; Korvick J; Ropka M; Heifets L; Clotfelter J; Munroe D; Horsburgh CR
    Clin Infect Dis; 1999 Jul; 29(1):125-33. PubMed ID: 10433575
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The management of mycobacterial infection--a UK survey.
    Lovering AM; White LO; Acaye C; Reeves DS; MacGowan AP
    J Antimicrob Chemother; 1995 Oct; 36(4):745-7. PubMed ID: 8591956
    [No Abstract]   [Full Text] [Related]  

  • 28. Prophylactic antibiotic receives speedy FDA approval to reduce MAC disease in advanced HIV.
    AIDS Patient Care STDS; 1996 Dec; 10(6):379. PubMed ID: 11361569
    [No Abstract]   [Full Text] [Related]  

  • 29. [Treatment with clarithromycin of 173 HIV+ patients with disseminated Mycobacterium avium intracellulare infection].
    Dautzenberg B; Saint-Marc T; Durant J; Reynes J; Meyohas MC; Legrand MF; Truffot C; Chauvin JP
    Rev Mal Respir; 1994; 11(3):271-6. PubMed ID: 8041990
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Liposome Company begins orphan drug phase II trials in AIDS patients with MAI.
    Oncology (Williston Park); 1991 Apr; 5(4):32. PubMed ID: 1831037
    [No Abstract]   [Full Text] [Related]  

  • 31. A patient with refractory disseminated Mycobacterium avium after immune-reconstitution localized MAC.
    Jenny-Avital ER
    AIDS Clin Care; 2003 Mar; 15(3):24-6. PubMed ID: 12685419
    [No Abstract]   [Full Text] [Related]  

  • 32. [Significance of Mycobacterium avium-intracellulare Complex in infections (review of the literature)].
    Filipovskiĭ AV
    Probl Tuberk; 1999; (5):45-8. PubMed ID: 10565219
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Disseminated Mycobacterium avium complex infection.
    Inderlied CB; Kemper CA
    AIDS Clin Rev; 1992; ():131-72. PubMed ID: 1606056
    [No Abstract]   [Full Text] [Related]  

  • 34. [Mycobacterium avium disease in AIDS patients; diagnosis and therapy].
    Weits J; Sprenger HG; Ilic P; van Klingeren B; Elema JD; Steensma JT
    Ned Tijdschr Geneeskd; 1991 Dec; 135(52):2485-9. PubMed ID: 1758516
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The management of mycobacterial infections in HIV seropositive individuals. Jefferiss Wing Therapeutics and Protocols Group.
    Fisher M; Tomlinson DR; Coker RJ
    Int J STD AIDS; 1996 Jul; 7(4):244-9; quiz 249-51. PubMed ID: 8876354
    [No Abstract]   [Full Text] [Related]  

  • 36. [The bacteriology of tuberculosis and non-tuberculosis mycobacterial infections].
    Wyplosz B; Truffot-Pernot C; Robert J; Jarlier V; Grosset J
    Rev Mal Respir; 1997 Dec; 14 Suppl 5():S33-48. PubMed ID: 9496590
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Failure of the radiometric Bactec method to detect Mycobacterium avium complex in the blood of patients infected with human immunodeficiency virus who were treated with antibiotics.
    Lebrun L; Livartowski J; May T; Dormont J; Nordmann P
    Clin Infect Dis; 1995 Nov; 21(5):1343-4. PubMed ID: 8589178
    [No Abstract]   [Full Text] [Related]  

  • 38. New trends in the drug therapy of localized and disseminated Mycobacterium avium complex infection.
    Sesin GP; Manzi SF; Pacheco R
    Am J Health Syst Pharm; 1996 Nov; 53(21):2585-90. PubMed ID: 8913387
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The treatment and prevention of mycobacterial disease in patients with HIV infection.
    Pitchenik AE
    AIDS; 1988; 2 Suppl 1():S177-82. PubMed ID: 3147668
    [No Abstract]   [Full Text] [Related]  

  • 40. Efficacy and safety of an intravenous induction therapy for treatment of disseminated Mycobacterium avium complex infection in AIDS patients: a pilot study.
    Roger PM; Carles M; Agussol-Foin I; Pandiani L; Keïta-Perse O; Mondain V; De Salvador F; Dellamonica P
    J Antimicrob Chemother; 1999 Jul; 44(1):129-31. PubMed ID: 10459822
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.